News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
702,198 Results
Type
Article (40468)
Company Profile (253)
Press Release (661477)
Multimedia
Podcasts (49)
Webinars (12)
Section
Business (204988)
Career Advice (2027)
Deals (35478)
Drug Delivery (96)
Drug Development (81198)
Employer Resources (172)
FDA (16227)
Job Trends (14926)
News (346324)
Policy (32641)
Tag
Academia (2603)
Academic (1)
Accelerated approval (5)
Adcomms (20)
Allergies (85)
Alliances (49743)
ALS (88)
Alzheimer's disease (1381)
Antibody-drug conjugate (ADC) (126)
Approvals (16229)
Artificial intelligence (256)
Autoimmune disease (22)
Automation (16)
Bankruptcy (362)
Best Places to Work (11665)
BIOSECURE Act (19)
Biosimilars (105)
Biotechnology (180)
Bladder cancer (78)
Brain cancer (27)
Breast cancer (281)
Cancer (2276)
Cardiovascular disease (175)
Career advice (1691)
Career pathing (31)
CAR-T (153)
Cell therapy (428)
Cervical cancer (19)
Clinical research (66101)
Collaboration (838)
Company closure (1)
Compensation (548)
Complete response letters (19)
COVID-19 (2604)
CRISPR (40)
C-suite (247)
Cystic fibrosis (100)
Data (2229)
Decentralized trials (2)
Denatured (18)
Depression (43)
Diabetes (272)
Diagnostics (6402)
Digital health (18)
Diversity (8)
Diversity, equity & inclusion (44)
Drug discovery (121)
Drug pricing (100)
Drug shortages (25)
Duchenne muscular dystrophy (93)
Earnings (86786)
Editorial (37)
Employer branding (21)
Employer resources (146)
Events (112854)
Executive appointments (734)
FDA (17511)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (7)
Funding (761)
Gene editing (106)
Generative AI (19)
Gene therapy (307)
GLP-1 (711)
Government (4442)
Grass and pollen (4)
Guidances (81)
Healthcare (18853)
Huntington's disease (24)
IgA nephropathy (27)
Immunology and inflammation (118)
Indications (29)
Infectious disease (2747)
Inflammatory bowel disease (141)
Inflation Reduction Act (8)
Influenza (52)
Intellectual property (96)
Interviews (314)
IPO (16529)
IRA (40)
Job creations (3669)
Job search strategy (1437)
Kidney cancer (10)
Labor market (38)
Layoffs (473)
Leadership (18)
Legal (7927)
Liver cancer (77)
Lung cancer (321)
Lymphoma (154)
Machine learning (7)
Management (58)
Manufacturing (308)
MASH (69)
Medical device (13413)
Medtech (13418)
Mergers & acquisitions (19500)
Metabolic disorders (692)
Multiple sclerosis (80)
NASH (16)
Neurodegenerative disease (90)
Neuropsychiatric disorders (27)
Neuroscience (1919)
NextGen: Class of 2025 (6538)
Non-profit (4510)
Now hiring (39)
Obesity (367)
Opinion (204)
Ovarian cancer (76)
Pain (88)
Pancreatic cancer (86)
Parkinson's disease (148)
Partnered (21)
Patents (237)
Patient recruitment (112)
Peanut (46)
People (57633)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase I (20622)
Phase II (29104)
Phase III (21673)
Pipeline (1228)
Policy (141)
Postmarket research (2568)
Preclinical (8774)
Press Release (68)
Prostate cancer (107)
Psychedelics (30)
Radiopharmaceuticals (246)
Rare diseases (378)
Real estate (5970)
Recruiting (65)
Regulatory (22357)
Reports (46)
Research institute (2362)
Resumes & cover letters (352)
Rett syndrome (5)
RNA editing (5)
RSV (42)
Schizophrenia (69)
Series A (131)
Series B (87)
Service/supplier (11)
Sickle cell disease (52)
Special edition (14)
Spinal muscular atrophy (148)
Sponsored (29)
Startups (3602)
State (2)
Stomach cancer (13)
Supply chain (68)
Tariffs (42)
The Weekly (29)
Vaccines (695)
Venture capitalists (41)
Weight loss (235)
Women's health (35)
Worklife (16)
Date
Today (180)
Last 7 days (821)
Last 30 days (2716)
Last 365 days (32793)
2025 (11005)
2024 (35270)
2023 (40146)
2022 (51247)
2021 (55816)
2020 (54213)
2019 (46701)
2018 (35184)
2017 (32283)
2016 (31673)
2015 (37790)
2014 (31485)
2013 (26560)
2012 (28759)
2011 (29446)
2010 (27558)
Location
Africa (722)
Alabama (53)
Alaska (7)
Arizona (232)
Arkansas (13)
Asia (38092)
Australia (6224)
California (6196)
Canada (2033)
China (527)
Colorado (266)
Connecticut (275)
Delaware (151)
Europe (81817)
Florida (916)
Georgia (208)
Idaho (57)
Illinois (540)
India (25)
Indiana (312)
Iowa (11)
Japan (165)
Kansas (104)
Kentucky (24)
Louisiana (10)
Maine (62)
Maryland (900)
Massachusetts (4616)
Michigan (220)
Minnesota (394)
Mississippi (2)
Missouri (81)
Montana (27)
Nebraska (25)
Nevada (64)
New Hampshire (63)
New Jersey (1748)
New Mexico (28)
New York (1764)
North Carolina (976)
North Dakota (8)
Northern California (2710)
Ohio (204)
Oklahoma (15)
Oregon (34)
Pennsylvania (1388)
Puerto Rico (12)
Rhode Island (33)
South America (1105)
South Carolina (23)
South Dakota (1)
Southern California (2333)
Tennessee (103)
Texas (924)
United States (23349)
Utah (183)
Virginia (150)
Washington D.C. (63)
Washington State (554)
West Virginia (3)
Wisconsin (55)
702,198 Results for "beacon biomedical inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
OcuSciences Announces FDA Marketing Clearance of OcuMet Beacon in Retinal Health Assessment at ARVO
May 1, 2025
·
2 min read
Press Releases
Bruker to Launch Beacon Discovery™ at AACR 2025, Expanding Access to Live Single-Cell Functional Analysis
April 24, 2025
·
4 min read
Business
Beacon Biosignals Selected by Longboard Pharmaceuticals to Advance Understanding of Epilepsy and Related Conditions
Beacon Biosignals announced a strategic partnership with Longboard Pharmaceuticals, Inc. that combines Longboard’s drug development expertise with Beacon’s neurophysiological platform to develop a better understanding of the relationship between sleep and neurological conditions with an initial focus in rare epileptic syndromes.
May 13, 2024
·
2 min read
Press Releases
Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis
February 7, 2025
·
3 min read
Press Releases
Beacon Therapeutics Granted FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for laru-zova (AGTC-501)
January 28, 2025
·
4 min read
Press Releases
Jasper Therapeutics Reports Positive Data from BEACON Study of Briquilimab in Chronic Spontaneous Urticaria
January 9, 2025
·
13 min read
Press Releases
Pliant Therapeutics Announces Next Steps Following DSMB Recommendation on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis
February 14, 2025
·
4 min read
Press Releases
Impact BioMedical Inc. to Present at The Microcap Conference
January 23, 2025
·
1 min read
Press Releases
electroCore, Inc. Announces Agreement with Spark Biomedical Inc. to Distribute Sparrow Ascent for Opioid Withdrawal
February 27, 2025
·
4 min read
Genetown
Beacon Therapeutics Treats First Patient in VISTA Registrational Trial for AGTC-501
Beacon Therapeutics Holdings Limited, a leading ophthalmic gene therapy company with a mission to save and restore the vision of patients with blinding retinal diseases, announced the treatment of the first patient in its registrational VISTA clinical trial with its lead asset, AGTC-501.
June 12, 2024
·
3 min read
1 of 70,220
Next
